Enlil Adds Eight MedTech Customers in Record First Quarter of 2026

May 15, 2026
Enlil announced a record first quarter of 2026, signing eight new MedTech customers that migrated from legacy quality and product lifecycle systems to its AI powered traceability platform.

Enlil announced in a press release that it signed eight new MedTech customers in the first quarter of 2026, marking a record start to the year. The companies span multiple medical technology areas, including organ perfusion, surgical robotics, imaging, and women's health.

The new customers, which include Vascular Perfusion Solutions, Verionyx, and iSono Health, migrated from legacy quality and product lifecycle management systems such as Greenlight Guru and PTC Arena. According to Enlil, its migration team supported these companies in transferring existing development data and establishing new processes without interrupting ongoing work.

Enlil's platform, built for medical device and life sciences organizations, integrates product development, quality, and compliance data with AI capabilities. The company stated that recent customers cited flexibility, integration, and private AI features as key reasons for adopting the platform.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly, Sales & Marketing AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.